Cargando…

Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials

Treatment of ventilated patients with gram-negative pneumonia (GNP) is often unsuccessful. We aimed to assess the efficacy and safety of nebulized amikacin (NA) as adjunctive therapy to systemic antibiotics in this patient population. PubMed, Embase, China national knowledge infrastructure, Wanfang,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Jun-Ping, Huang, Hui-Bin, Zhou, Hua, Zhu, Yuan, Xu, Yuan, Du, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997905/ https://www.ncbi.nlm.nih.gov/pubmed/33772055 http://dx.doi.org/10.1038/s41598-021-86342-8

Ejemplares similares

Effect of extended infusion of meropenem and nebulized amikacin on Gram-negative multidrug-resistant ventilator-associated pneumonia
por: Ammar, Mona Ahmed, et al.
Publicado: (2018)

Decrease in intravenous antibiotic use with adjunctive aerosolized amikacin treatment in intubated mechanically ventilated patients with Gram-negative pneumonia
por: Niederman, M, et al.
Publicado: (2007)

Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
por: Liu, Chang, et al.
Publicado: (2017)

Inhaled ceftazidime and amikacin versus inhaled colistin in the treatment of gram negative ventilator associated pneumonia
por: Nassar, YS, et al.
Publicado: (2015)

A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
por: El Fawy, Dalia M., et al.
Publicado: (2020)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators
por: Dequin, P, et al.
Publicado: (2004)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Adjunctive inhaled amikacin in infants with ventilator-associated pneumonia optimizes the complex antimicrobial therapy: pilot study
por: Levchenko, Bohdan, et al.
Publicado: (2023)

Randomized Control Study of Nebulized Colistin as an Adjunctive Therapy in Ventilator-Associated Pneumonia in Pediatric Postoperative Cardiac Surgical Population
por: Bharathi, K. S., et al.
Publicado: (2022)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
por: Wu, Zhenping, et al.
Publicado: (2023)

Nebulized antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis
por: Zampieri, Fernando G, et al.
Publicado: (2015)

Budesonide Nebulization in the Treatment of Neonatal Ventilator Associated Pneumonia
por: Li, Baoqiang, et al.
Publicado: (2017)

In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
por: Cuba, Gabriel T., et al.
Publicado: (2022)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Nebulized antibiotics for ventilator-associated pneumonia: misleading analysis and interpretation of the data
por: Gu, Wan-Jie
Publicado: (2015)

Adjunctive Nebulized Antibiotics: What Is Their Place in ICU Infections?
por: Niederman, Michael S.
Publicado: (2019)

Characteristics of Carbapenem-Resistant Gram-Negative Bacilli in Patients with Ventilator-Associated Pneumonia
por: Mohamed, Amira, et al.
Publicado: (2021)

Evaluating antibiotic therapy for ventilator-associated pneumonia caused by gram-negative bacilli
por: Malhotra, Raj, et al.
Publicado: (2023)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects
por: Torres, Antoni, et al.
Publicado: (2018)

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
por: Zhu, Yinggang, et al.
Publicado: (2021)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective study
por: Doshi, Neha M, et al.
Publicado: (2013)

Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains
por: Rahmati, Mohamad, et al.
Publicado: (2022)

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
por: Luyt, Charles-Edouard, et al.
Publicado: (2009)

NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects
por: Eldon, M, et al.
Publicado: (2008)

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria
por: Luna, Brian M, et al.
Publicado: (2019)

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
por: Mabrouk, Samar S., et al.
Publicado: (2023)

Use of direct Etest in the management of ventilator-associated pneumonia due to resistant Gram-negative pathogens
por: Partridge, David, et al.
Publicado: (2008)

Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
por: Tavernier, Elsa, et al.
Publicado: (2021)

New antibiotics for Gram-negative pneumonia
por: Bassetti, Matteo, et al.
Publicado: (2022)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2013)

Empirical Antibiotic Therapy for Gram-Negative Bacilli Ventilator-Associated Pneumonia: Observational Study and Pharmacodynamic Assessment
por: Pajot, Olivier, et al.
Publicado: (2022)

Effectiveness of adjunctive nebulized antibiotics in critically ill patients with respiratory tract infections
por: Leache, Leire, et al.
Publicado: (2019)

2231. Safety of Nebulized Colistin as Adjunctive Treatment of Lower Respiratory Tract Infections
por: Nadeem, Komal, et al.
Publicado: (2019)

Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol
por: Erfani, Yousef, et al.
Publicado: (2016)

Nebulized heparin for patients under mechanical ventilation: an individual patient data meta-analysis
por: Glas, Gerie J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0jj4qgl3p8dicu9t6btd2t76rq